154 related articles for article (PubMed ID: 19621374)
1. The serum protein binding of pharmacologically active gallium(III) compounds assessed by hyphenated CE-MS techniques.
Groessl M; Bytzek A; Hartinger CG
Electrophoresis; 2009 Aug; 30(15):2720-7. PubMed ID: 19621374
[TBL] [Abstract][Full Text] [Related]
2. Metallomics for drug development: serum protein binding and analysis of an anticancer tris(8-quinolinolato)gallium(III) drug using inductively coupled plasma mass spectrometry.
Ossipov K; Foteeva LS; Seregina IF; Perevalov SA; Timerbaev AR; Bolshov MA
Anal Chim Acta; 2013 Jun; 785():22-6. PubMed ID: 23764439
[TBL] [Abstract][Full Text] [Related]
3. A versatile approach for assaying in vitro metallodrug metabolism using CE hyphenated with ICP-MS.
Abramski JK; Foteeva LS; Pawlak K; Timerbaev AR; Jarosz M
Analyst; 2009 Oct; 134(10):1999-2002. PubMed ID: 19768206
[TBL] [Abstract][Full Text] [Related]
4. Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: a novel approach for the analysis of anticancer metallodrugs in human serum and plasma.
Groessl M; Hartinger CG; Polec-Pawlak K; Jarosz M; Keppler BK
Electrophoresis; 2008 May; 29(10):2224-32. PubMed ID: 18512673
[TBL] [Abstract][Full Text] [Related]
5. Platinum group metallodrug-protein binding studies by capillary electrophoresis - inductively coupled plasma-mass spectrometry: a further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins.
Polec-Pawlak K; Abramski JK; Semenova O; Hartinger CG; Timerbaev AR; Keppler BK; Jarosz M
Electrophoresis; 2006 Mar; 27(5-6):1128-35. PubMed ID: 16440400
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the anticancer gallium(III) complexes of 8-hydroxyquinoline and maltol with human serum proteins.
Enyedy ÉA; Dömötör O; Bali K; Hetényi A; Tuccinardi T; Keppler BK
J Biol Inorg Chem; 2015 Jan; 20(1):77-88. PubMed ID: 25398250
[TBL] [Abstract][Full Text] [Related]
7. Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins.
Rudnev AV; Foteeva LS; Kowol C; Berger R; Jakupec MA; Arion VB; Timerbaev AR; Keppler BK
J Inorg Biochem; 2006 Nov; 100(11):1819-26. PubMed ID: 16938349
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of gallium chloride and tris (8-quinolinolato) gallium III on A549 human malignant cell line.
Collery P; Lechenault F; Cazabat A; Juvin E; Khassanova L; Evangelou A; Keppler B
Anticancer Res; 2000; 20(2A):955-8. PubMed ID: 10810380
[TBL] [Abstract][Full Text] [Related]
9. Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediates.
Davies NP; Suryo Rahmanto Y; Chitambar CR; Richardson DR
J Pharmacol Exp Ther; 2006 Apr; 317(1):153-62. PubMed ID: 16373528
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics.
Zhao H; Wang S; Nguyen SN; Elci SG; Kaltashov IA
J Am Soc Mass Spectrom; 2016 Feb; 27(2):211-9. PubMed ID: 26392277
[TBL] [Abstract][Full Text] [Related]
11. Comparative serum albumin interactions and antitumor effects of Au(III) and Ga(III) ions.
Sarioglu OF; Ozdemir A; Karaboduk K; Tekinay T
J Trace Elem Med Biol; 2015 Jan; 29():111-5. PubMed ID: 25049057
[TBL] [Abstract][Full Text] [Related]
12. Determination of gallium originated from a gallium-based anticancer drug in human urine using ICP-MS.
Filatova DG; Seregina IF; Foteeva LS; Pukhov VV; Timerbaev AR; Bolshov MA
Anal Bioanal Chem; 2011 May; 400(3):709-14. PubMed ID: 21359996
[TBL] [Abstract][Full Text] [Related]
13. Gallium-pyridoxal isonicotinoyl hydrazone (Ga-PIH), a novel cytotoxic gallium complex. A comparative study with gallium nitrate.
Knorr GM; Chitambar CR
Anticancer Res; 1998; 18(3A):1733-7. PubMed ID: 9673397
[TBL] [Abstract][Full Text] [Related]
14. Reconsideration of serum Ti(IV) transport: albumin and transferrin trafficking of Ti(IV) and its complexes.
Tinoco AD; Eames EV; Valentine AM
J Am Chem Soc; 2008 Feb; 130(7):2262-70. PubMed ID: 18225897
[TBL] [Abstract][Full Text] [Related]
15. Gallium and other main group metal compounds as antitumor agents.
Jakupec MA; Keppler BK
Met Ions Biol Syst; 2004; 42():425-62. PubMed ID: 15206110
[TBL] [Abstract][Full Text] [Related]
16. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
Chitambar CR; Zivkovic-Gilgenbach Z; Narasimhan J; Antholine WE
Cancer Res; 1990 Aug; 50(15):4468-72. PubMed ID: 2164439
[TBL] [Abstract][Full Text] [Related]
17. Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex.
Sakajiri T; Yamamura T; Kikuchi T; Ichimura K; Sawada T; Yajima H
Biol Trace Elem Res; 2010 Sep; 136(3):279-86. PubMed ID: 19859668
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells.
Kasai K; Hori MT; Goodman WG
Endocrinology; 1990 Mar; 126(3):1742-9. PubMed ID: 2307125
[TBL] [Abstract][Full Text] [Related]
19. Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin.
Timerbaev AR; Aleksenko SS; Polec-Pawlak K; Ruzik R; Semenova O; Hartinger CG; Oszwaldowski S; Galanski M; Jarosz M; Keppler BK
Electrophoresis; 2004 Jul; 25(13):1988-1995. PubMed ID: 15237398
[TBL] [Abstract][Full Text] [Related]
20. Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells.
Chitambar CR; Sax D
Blood; 1992 Jul; 80(2):505-11. PubMed ID: 1627803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
